Status:
COMPLETED
The Expression and Significance of MiRNA
Lead Sponsor:
Megan Ballinger
Conditions:
Pulmonary Arterial Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
It is not always known what causes PAH or what the best treatment is. The doctors doing this study would like to understand more about why some people develop PAH and other do not. They also would lik...
Detailed Description
You will be asked to donate blood when you have your right heart catheterization and also at the 3-4 month follow-up visit. The amount of blood collected during your heart catheterization is about 20c...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Not pregnant
- Undergoing right heart catheterization for PAH diagnosis
Exclusion
- Pregnant
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 16 2018
Estimated Enrollment :
207 Patients enrolled
Trial Details
Trial ID
NCT00806312
Start Date
July 1 2008
End Date
August 16 2018
Last Update
November 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210